Search
for
Sort by
Research 61–90 of 580
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy
- 1332 Janus kinase inhibitor increases hair growth by increasing beta-catenin activity in outer root sheath cells
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Recent Advances in Drug Development for Hair Loss
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- CXCL12 inhibits hair growth through CXCR4
- Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Role and Mechanisms of Phytochemicals in Hair Growth and Health
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Autoinmune Alopecia/Alopecia Areata
- Vitiligo—Current Treatment Options and Future Perspectives
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- Alopecia areata – Aktuelles Verständnis und Management
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Phytochemicals for Hair Health Targeting Growth Signaling Molecules in Hair Follicular Stem Cells: A New Strategy for Hair Growth
- IN-SILICO STUDY OF BIOACTIVE COMPOUNDS OF NATURAL MATERIALS AS A JAK- SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION INHIBITOR FOR ANTI-ALOPECIA